Detalhe da pesquisa
1.
COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
J Gastroenterol Hepatol
; 36(11): 3033-3040, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151470
2.
IBD barriers across the continents: a continent-specific analysis: Latin America.
Therap Adv Gastroenterol
; 16: 17562848231167953, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124371
3.
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.
Therap Adv Gastroenterol
; 16: 17562848231210053, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026104
4.
Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases.
Front Med (Lausanne)
; 9: 864888, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35966848
5.
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey.
World J Gastroenterol
; 27(12): 1226-1239, 2021 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828396